KR-36996, an orally active urotensin II receptor antagonist, attenuates hepatic inflammation and fibrosis in methionine- and choline-deficient diet-induced fibrosing steatohepatitis

Peptides · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles